Abstract:Activation of beta adrenergic receptors leads to vasodilation. Experimental evidence suggests that such an effect may involve ATP-sensitive K+ (KATP) channels and protein kinase A, although the PKA-dependence is not fully settled. One way to address this issue is to demonstrate that functional phosphorylation of the channel protein. Therefore, we performed studies on Kir6.1/SUR2B channel expressed in HEK cells. Isoproterenol activated the Kir6.1/SUR2B channel with EC50 4.3nM. Similar channel activation was seen with forskolin and intracellular dialysis of cAMP. The channel activation was strongly suppressed with PKA inhibitors. Since none of the previously reported PKA sites (Ser385 in Kir6.1 and Thr633, Ser1465 in SUR2B) accounted for the channel activation, we performed systematic mutational analysis of all PKA consensus sequences in Kir6.1 and SUR2B. Critical residues were found in SUR2B for the channel activation by PKA. Mutation of any of them to alanine was sufficient to eliminate the channel activation by isoproterenol and forskolin. In contract, site-specific mutation of putative PKA sites in Kir6.1 had no effect. These results thus indicate that the Kir6.1/SUR2B channel is a down-stream effector of beta2 receptors, and the channel is directly phosphorylated by PKA.

SUR2B Phosphorylation by Protein Kinase A Underscores Vascular KATP Channel Activation by Beta Adrenergic Receptor Stimulation